|
As reported, post implant of the xenmatrix graft, the patient was diagnosed with a hernia recurrence, and subsequent infection.Patient underwent additional surgery for removal of the graft.The clinician has assessed the patient¿s postoperative course as being possibly related to the study device and possibly related to the procedure.However, based on the information provided, no conclusion can be made.Review of manufacturing records confirms product was manufactured to specification.To date, this is the only reported complaint for this manufacturing lot of (b)(4) units released for distribution in may 2014.Hernia recurrence and infection are known inherent risks of the surgery and are included as possible complications in the adverse reactions section of the instructions-for-use (ifu), supplied with the device.Regarding infection, the warnings section of the ifu states, " if an infection develops, it should be treated aggressively.¿ not returned - mesh explanted.
|
|
Per clinical trial dvl-he-020: on (b)(6) 2015, the patient underwent primary open hernia repair procedure for ventral hernia in llq location during which a xenmatrix surgical graft was trimmed and placed in underlay fashion in the intra-peritoneal region using sutures.Full skin closure was achieved using sutures with figure-8 technique.Concomitant procedure includes debridement of abdominal wall nonhealing wound.The patient was discharged on (b)(6) 2015.As reported, during a physical examination on (b)(6) 2015 the patient was diagnosed with ventral hernia recurrence in llq location.As reported on (b)(6) 2015, the patient was diagnosed with surgical site infection (ssi) and the culture test for the tissue was positive for staphylococcus aureus and treated with oral antibiotics/antimicrobials and resolved on (b)(6) 2016.It was reported that on (b)(6) 2016, the patient underwent reoperation to repair hernia recurrence and the graft was removed completely.Full skin closure was achieved using vicryl interrupted stitch.The patient was discharged on (b)(6) 2016.The ae (hernia recurrence and surgical site infection (ssi)) is clinically assessed to be moderate in severity, possibly related to the study device and possibly related to the index procedure and recovered/resolved.The reported ae (hernia recurrence) does meet the definition of serious (sae) and ae (surgical site infection (ssi)) does not meet the definition of serious (sae).
|